热门资讯> 正文
埃隆·马斯克（Elon Musk）的Neuralink将在英国测试大脑芯片
2025-08-01 13:28
- Neuralink, the neurotechnology company co-founded by Tesla (NASDAQ:TSLA) CEO Elon Musk, said on Thursday it will launch a clinical study in Great Britain to test how its chips can help patients with severe paralysis to control digital and physical tools with their thoughts.
- The company is partnering with the University College London Hospitals Trust and Newcastle Hospitals to conduct the study, it said in a post on X.
- According to Neuralink, patients living with paralysis due to conditions such as spinal cord injury and a nervous system disease called Amyotrophic Lateral Sclerosis (ALS) qualify to participate in the study.
- Musk, who also leads internet service provider Starlink (STRLK) and space exploration company SpaceX (SPACE), previously said that Neuralink aims to implant Blindsight in a human for the first time later this year.
More on Tesla
- Tesla: Distracted Company, Weak FSD (Double Downgrade)
- Tesla Valuation Is Built On Dreams
- Tesla Earnings Show Its Core Business Is Struggling
- Tesla launches a ride-hailing service in the San Francisco area featuring chauffeurs, not robotaxis
- The week after: How has Tesla performed since Q2 earnings?
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
